0001683168-21-001020.txt : 20210322
0001683168-21-001020.hdr.sgml : 20210322
20210322173017
ACCESSION NUMBER: 0001683168-21-001020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210318
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lockshin Curtis
CENTRAL INDEX KEY: 0001383556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37937
FILM NUMBER: 21762263
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BOULEVARD
STREET 2: SUITE 950
CITY: MIAMI
STATE: FL
ZIP: 33137
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
4
1
ownership.xml
X0306
4
2021-03-18
0
0001534525
Xenetic Biosciences, Inc.
XBIO
0001383556
Lockshin Curtis
40 SPEEN STREET, SUITE 102
FRAMINGHAM
MA
01701
0
1
0
0
Chief Sciencific Officer
Stock Options
2.60
2021-03-18
4
A
0
50000
0
A
2031-03-18
Common Stock
50000
50000
D
The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024.
/s/ Curtis A. Lockshin
2021-03-22